TMCnet News
Prestige Brands Holdings, Inc. to Release Fiscal 2013 Third Quarter Earnings on February 7thTARRYTOWN, N.Y. --(Business Wire)-- Prestige Brands Holdings, Inc. (NYSE: PBH) today announced that it will issue its fiscal 2013 third quarter earnings release on Thursday, February 7, 2013 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. EST. To access the call, listeners calling from within North America may dial 866-578-5788 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 617-213-8057. The conference pass code is "prestige". The Company will provide a live internet web cast as well as an archived replay, which can be accessed from the Investor Relations page of < rel="nofollow" href="http://cts.businesswire.com/ct/CT id=smartlink&url=http%3A%2F%2Fprestigebrands.com&esheet=50532449&lan=en-US&anchor=http%3A%2F%2Fprestigebrands.com&index=1&md5=d7f658cf502d7393321c5ffc512243c6">http://prestigebrands.com. Telephonic replays will be available for two weeks following completion of the live call and can be accessed at 888-286-8010 within North America, and at 617-801-6888 from outside North America. The pass code is 31315331. Prestige Brands markets and distributes brand name over-the-counter healthcare and household products throughout the United States, Canada and certain international markets. Core brands include Chloraseptic® sore throat treatments, Compound W® wart treatments, Clear Eyes® eye care products, Little Remedies® and PediaCare® pediatric over-the-counter healthcare products, The Doctor's® NightGuard® dental protector, Efferdent® denture care products, Luden's® throat drops, Dramamine® motion sickness treatment, BC® and Goody's® headache remedies, Beano® gas prevention, Debrox® earwax remover, and Gaviscon® antacid.
|
